Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.

Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.

Dihydroartemisinin-piperaquine (DP) could become a leading fixed combination malaria treatment worldwide. Although there is accumulating evidence of efficacy and safety from clinical trials, data on cardiotoxicity are limited. In two randomized controlled trials in Thailand, 56 patients had ECGs per...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Mytton, O, Ashley, E, Peto, L, Price, R, La, Y, Hae, R, Singhasivanon, P, White, N, Nosten, F
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2007

Eitemau Tebyg

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
gan: Rijken, M, et al.
Cyhoeddwyd: (2011)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
gan: Tarning, J, et al.
Cyhoeddwyd: (2007)

Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children.
gan: Karema, C, et al.
Cyhoeddwyd: (2006)

Efficacy and safety of dihydroartemisinin-piperaquine.
gan: Myint, H, et al.
Cyhoeddwyd: (2007)

Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
gan: Ashley, E, et al.
Cyhoeddwyd: (2004)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
gan: Tarning, J, et al.
Cyhoeddwyd: (2012)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
gan: Tarning, J, et al.
Cyhoeddwyd: (2012)

Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers
gan: Chotsiri, P, et al.
Cyhoeddwyd: (2017)

A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria.
gan: Ashley, E, et al.
Cyhoeddwyd: (2005)

Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: A prospective multi-centre individual patient data analysis
gan: Zwang, J, et al.
Cyhoeddwyd: (2009)

Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis.
gan: Zwang, J, et al.
Cyhoeddwyd: (2009)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
gan: Zongo, I, et al.
Cyhoeddwyd: (2014)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.
gan: Ashley, E, et al.
Cyhoeddwyd: (2010)

A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru
gan: Grande, T, et al.
Cyhoeddwyd: (2007)

Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants.
gan: Creek, D, et al.
Cyhoeddwyd: (2013)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
gan: Tarning, J, et al.
Cyhoeddwyd: (2008)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria
gan: Ashley, E, et al.
Cyhoeddwyd: (2010)

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy
gan: Poespoprodjo, JR, et al.
Cyhoeddwyd: (2014)

Dihydroartemisinin-piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report.
gan: Rijken, M, et al.
Cyhoeddwyd: (2008)

Treatment failure of dihydroartemisinin/piperaquine for plasmodium falciparum malaria, Vietnam
gan: Phuc, B, et al.
Cyhoeddwyd: (2017)

Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.
gan: Phyo, A, et al.
Cyhoeddwyd: (2011)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
gan: Tarning, J, et al.
Cyhoeddwyd: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
gan: Tarning, J, et al.
Cyhoeddwyd: (2012)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
gan: Adam, I, et al.
Cyhoeddwyd: (2012)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
gan: Adam, I, et al.
Cyhoeddwyd: (2012)

Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria.
gan: Mcgready, R, et al.
Cyhoeddwyd: (2006)

Treatment-seeking behavior after the implementation of a unified policy of dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua, Indonesia
gan: Devine, A, et al.
Cyhoeddwyd: (2017)

Dihydroartemisinin - piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report
gan: Rijken, M, et al.
Cyhoeddwyd: (2007)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
gan: Mcgready, R, et al.
Cyhoeddwyd: (2006)

An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos).
gan: Mayxay, M, et al.
Cyhoeddwyd: (2006)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
gan: McGready, R, et al.
Cyhoeddwyd: (2009)

Evolution of genetic markers for drug resistance after the introduction of dihydroartemisinin–piperaquine as first-line anti-malarial treatment for uncomplicated falciparum malaria in Indonesia
gan: Rahmasari, FV, et al.
Cyhoeddwyd: (2023)

Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
gan: Tarning, J, et al.
Cyhoeddwyd: (2012)

Efficacy and safety of dihydroartemisinin–piperaquine for treatment of Plasmodium falciparum uncomplicated malaria in adult patients on antiretroviral therapy in Malawi and Mozambique: an open label non-randomized interventional trial
gan: Sevene, E, et al.
Cyhoeddwyd: (2019)

Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria.
gan: Ashley, E, et al.
Cyhoeddwyd: (2006)

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
gan: Smithuis, F, et al.
Cyhoeddwyd: (2006)

A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos.
gan: Mayxay, M, et al.
Cyhoeddwyd: (2010)

Electrocardiographic monitoring in severe falciparum malaria.
gan: Bethell, D, et al.
Cyhoeddwyd: (1996)

Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.
gan: Tran, T, et al.
Cyhoeddwyd: (2004)

Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.
gan: Tarning, J, et al.
Cyhoeddwyd: (2013)